Healthcare provider profile · identity verified

Darrin Lyons, M.D.

Family Practice · OAKLAND, TN · NPI 1285658237

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Montelukast Sodium	Montelukast Sodium	705	197
Amlodipine Besylate	Amlodipine Besylate	482	144
Omeprazole	Omeprazole	476	107
Azithromycin	Azithromycin	427	189
Simvastatin	Simvastatin	411	93
Losartan Potassium	Losartan Potassium	368	109
Atorvastatin Calcium	Atorvastatin Calcium	357	106
Prednisone	Prednisone	319	163
Levothyroxine Sodium	Levothyroxine Sodium	272	55
Potassium Chloride	Potassium Chloride	253	63
Rosuvastatin Calcium	Rosuvastatin Calcium	248	93
Metformin Hcl	Metformin Hcl	239	68
Tamsulosin Hcl	Tamsulosin Hcl	217	54
Gabapentin	Gabapentin	207	55
Albuterol Sulfate Hfa	Albuterol Sulfate	190	59
Ezetimibe	Ezetimibe	190	59
Hydrochlorothiazide	Hydrochlorothiazide	160	47
Allopurinol	Allopurinol	148	41
Pantoprazole Sodium	Pantoprazole Sodium	143	36
Lisinopril	Lisinopril	123	38
Glimepiride	Glimepiride	117	30
Metoprolol Tartrate	Metoprolol Tartrate	114	39
Tramadol Hcl	Tramadol Hcl	112	39
Alendronate Sodium	Alendronate Sodium	93	20
Fluconazole	Fluconazole	89	32
Tradjenta	Linagliptin	89	29
Furosemide	Furosemide	88	27
Januvia	Sitagliptin Phosphate	88	18
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	82	51
Trazodone Hcl	Trazodone Hcl	82	22
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	81	45
Meloxicam	Meloxicam	80	27
Lovastatin	Lovastatin	79	24
Naproxen	Naproxen	79	42
Doxycycline Hyclate	Doxycycline Hyclate	77	61
Famotidine	Famotidine	77	24
Metoprolol Succinate	Metoprolol Succinate	76	24
Ciprofloxacin Hcl	Ciprofloxacin Hcl	75	55
Alprazolam	Alprazolam	71	13
Clonazepam	Clonazepam	71	12
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	66	15
Hydralazine Hcl	Hydralazine Hcl	63	18
Pravastatin Sodium	Pravastatin Sodium	63	17
Carvedilol	Carvedilol	60	18
Atenolol	Atenolol	58	13
Fluoxetine Hcl	Fluoxetine Hcl	58	19
Fenofibrate	Fenofibrate Nanocrystallized	57	13
Eliquis	Apixaban	55	14
Topiramate	Topiramate	55	15
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	54	16
Clopidogrel	Clopidogrel Bisulfate	53	16
Levetiracetam	Levetiracetam	53	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	51	14
Lorazepam	Lorazepam	51	suppressed
Citalopram Hbr	Citalopram Hydrobromide	49	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	49	35
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	48	24
Fluticasone Propionate	Fluticasone Propionate	48	15
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	47	11
Linzess	Linaclotide	47	18
Finasteride	Finasteride	46	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	45	13
Paroxetine Hcl	Paroxetine Hcl	44	suppressed
Sucralfate	Sucralfate	43	suppressed
Ondansetron Odt	Ondansetron	42	23
Cyproheptadine Hcl	Cyproheptadine Hcl	41	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	39	13
Sertraline Hcl	Sertraline Hcl	38	11
Benazepril Hcl	Benazepril Hcl	37	13
Metronidazole	Metronidazole	37	34
Neomycin-Polymyxin-Hc	Neomycin/Polymyxin B/Hydrocort	37	26
Meclizine Hcl	Meclizine Hcl	36	16
Ozempic	Semaglutide	36	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	34	15
Donepezil Hcl	Donepezil Hcl	33	11
Escitalopram Oxalate	Escitalopram Oxalate	33	suppressed
Metformin Hcl Er	Metformin Hcl	32	suppressed
Farxiga	Dapagliflozin Propanediol	31	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	31	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	30	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	30	suppressed
Levofloxacin	Levofloxacin	29	23
Olmesartan Medoxomil	Olmesartan Medoxomil	29	suppressed
Solifenacin Succinate	Solifenacin Succinate	28	suppressed
Valsartan	Valsartan	28	suppressed
Glipizide	Glipizide	27	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Duloxetine Hcl	Duloxetine Hcl	26	suppressed
Midodrine Hcl	Midodrine Hcl	25	suppressed
Tizanidine Hcl	Tizanidine Hcl	25	22
Clonidine Hcl	Clonidine Hcl	24	suppressed
Methotrexate	Methotrexate Sodium	24	suppressed
Nifedipine Er	Nifedipine	23	suppressed
Ropinirole Hcl	Ropinirole Hcl	23	suppressed
Spironolactone	Spironolactone	23	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	12
Chlorthalidone	Chlorthalidone	22	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	22	suppressed
Ofloxacin	Ofloxacin	22	15
Metoclopramide Hcl	Metoclopramide Hcl	21	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	21	11
Valacyclovir	Valacyclovir Hcl	21	suppressed
Celecoxib	Celecoxib	20	suppressed
Colchicine	Colchicine	20	suppressed
Hydrocortisone	Hydrocortisone	20	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	20	19
Verapamil Er	Verapamil Hcl	20	suppressed
Cefdinir	Cefdinir	19	suppressed
Ibandronate Sodium	Ibandronate Sodium	19	suppressed
Amiodarone Hcl	Amiodarone Hcl	18	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Buspirone Hcl	Buspirone Hcl	18	suppressed
Carbamazepine	Carbamazepine	18	suppressed
Jardiance	Empagliflozin	18	suppressed
Ketoconazole	Ketoconazole	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Ibuprofen	Ibuprofen	17	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	17	suppressed
Mupirocin	Mupirocin	17	16
Promethazine Hcl	Promethazine Hcl	17	suppressed
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Pregabalin	Pregabalin	16	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	16	suppressed
Amoxicillin	Amoxicillin	15	12
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Klor-Con M20	Potassium Chloride	15	suppressed
Olanzapine	Olanzapine	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Terazosin Hcl	Terazosin Hcl	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Folic Acid	Folic Acid	14	suppressed
Labetalol Hcl	Labetalol Hcl	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	13	suppressed
Estradiol	Estradiol	13	suppressed
Mounjaro	Tirzepatide	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Sprintec	Norgestimate-Ethinyl Estradiol	13	suppressed
Telmisartan	Telmisartan	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Aptiom	Eslicarbazepine Acetate	12	suppressed
Imipramine Hcl	Imipramine Hcl	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Clindamycin Hcl	Clindamycin Hcl	11	suppressed
Constulose	Lactulose	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Gemtesa	Vibegron	11	suppressed
Methylprednisolone	Methylprednisolone	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Ramipril	Ramipril	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Tobramycin	Tobramycin	11	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error